Article info

Download PDFPDF
Extended report
Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry)
  1. Correspondence to J Augustsson, Department of Medicine, Rheumatology Unit, Karolinska Institute, Karolinska University Hospital Solna, Stockholm, SE-171 76, Sweden; jenny.augustsson{at}ki.se
View Full Text

Citation

Augustsson J, Neovius M, Cullinane-Carli C, et al
Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry)

Publication history

  • Accepted April 30, 2009
  • First published May 25, 2009.
Online issue publication 
December 09, 2009

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.